Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Eleven Biotherapeutics EBIO

"Eleven Biotherapeutics Inc is a biotechnology-based firm in the United States. It is engaged in the development of therapeutics to cure diseases related to the eye."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:EBIO)

Mid-Afternoon Market Update: Blink Charging Rises After Q1 Results; Purple Innovation Shares Slide

Benzinga.com  May 16, 2018

Mid-Day Market Update: Abaxis Climbs On Acquisition News; Evolus Shares Plunge

Benzinga.com  May 16, 2018

Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings

Benzinga.com  May 16, 2018

Eleven Biotherapeutics Announces Corporate Name Change to Sesen Bio

Business Wire May 16, 2018

Eleven Biotherapeutics Reports First Quarter Financial Results and Pipeline Updates

Business Wire May 15, 2018

Market Trends Toward New Normal in Emerge Energy Services LP, NACCO Industries, 8x8, Eleven Biotherapeutics, Monolithic Power, and Highwoods Properties — Emerging Consolidated Expectations, Analyst Ratings

GlobeNewswire May 1, 2018

Benzinga's Biotech Pulse: Takeda Sweetens Shire Offer Again, Menlo's Woes Abound, Earnings Fail to Boost Amgen

Benzinga.com  April 25, 2018

New Preclinical Data Highlighting Eleven Biotherapeutics’ DeBouganin Program to be Presented at 2018 AACR Annual Meeting

Business Wire April 12, 2018

Eleven Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Operating Results and Vicinium Development Progress

Business Wire April 4, 2018

Opinion & Analysis (NDAQ:EBIO)

No current opinion is available.

Bullboard Posts (NDAQ:EBIO)